NEEDLE AND SYRINGE EXCHANGE AS A METHOD OF AIDS EPIDEMIC CONTROL NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


NEEDLE AND SYRINGE EXCHANGE AS A METHOD OF AIDS EPIDEMIC CONTROL

AIDS Updates; 2(5):1-8 1989. Unique Identifier : AIDSLINE ICDB/90660518
Joseph SC; Des Jarlais DC; Dept. of Health, New York, NY


Abstract: The use of needle and syringe exchanges as a method of preventing HIV infection among people who inject illicit drugs is reviewed, and a case history of the pilot exchange program in New York City is presented. In addition to reducing the spread of HIV infection, syringe exchange programs provide for safe disposal of possibly contaminated injection equipment and, even more importantly, provide opportunities for delivering additional health-related services such as referrals for drug-abuse treatment and counseling about sexual transmission of HIV. Problems associated with the operation of a syringe exchange include community acceptance, acceptance by drug-injecting clients, and coverage of each of the many injections of the drug user. Rigorous, scientific evaluation of the effectiveness of exchange programs is extremely difficult, but all of the studies that have been conducted consistently report that participation is associated with reduction, but not elimination, of transmission of HIV. The available data do not support the proposition that exchanges lead to increased drug injection, and, in fact, the New York City exchange program is proving highly effective as a supportive bridge to drug treatment programs. The authors argue that the New York City program is helping to change and save the lives of a limited number of iv drug users and should be expanded and adapted by other communities as one element in a comprehensive AIDS prevention program. (15 Refs)
Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL Disease Outbreaks/*PREVENTION & CONTROL Human *Needles New York City Risk Factors *Substance Abuse, Intravenous *Syringes JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDprevention&controldiseaseoutbreaks/KWDprevention&controlhumanKWDneedlesnewyorkcityriskfactorsKWDsubstanceabuse,intravenousKWDsyringesjournalarticle
910228
M9120719

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .